Related Experiment Video
Updated: May 22, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
Application of engineered exosomes in tumor therapy
Chunhui Ma1, Wei Tang2, Jiaye Wang2
1Faculty of Medical Imaging, Naval Medical University Shanghai 200433, China.
Engineered exosomes offer a promising solution for targeted cancer therapy due to their biocompatibility and low toxicity. This review explores their potential in overcoming limitations of conventional treatments.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Malignant tumors represent a major global health challenge.
- Conventional cancer therapies often lack specificity, causing significant side effects.
- Exosomes, as natural intercellular communicators, possess inherent biocompatibility and low toxicity.
Purpose of the Study:
- To review engineered exosomes as targeted delivery vehicles for cancer therapy.
- To summarize exosome engineering strategies and applications.
- To identify challenges in clinical translation of exosome-based therapies.
Main Methods:
- Review of literature on exosome biogenesis and engineering.
- Analysis of exosome modification techniques for drug delivery.
- Discussion of exosome-based therapeutic strategies in preclinical and clinical studies.
Main Results:
- Engineered exosomes can be tailored for enhanced tumor targeting and drug delivery.
- Various methods exist for exosome production, modification, and drug loading.
- Exosomes demonstrate potential in overcoming drug resistance and reducing systemic toxicity.
Conclusions:
- Engineered exosomes hold significant promise for advancing targeted cancer treatment.
- Further research is needed to address challenges in large-scale production and clinical implementation.
- Exosome engineering offers a novel platform for developing next-generation cancer therapeutics.
More Related Videos
09:30Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...